2015 ACBS Landline-Cellphone Combined Prevalence Tables
BRFSS Asthma Call-back Survey Prevalence TABLE 10
TABLE 10. Estimated percent using inhaled short acting beta agonists among adults1
with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey Landline And Cell Phone Combined Sample, United States, 2015
State/Territory |
Current |
Active |
Sample
size±
|
% |
SE§
|
95% CI†
|
Sample
size |
% |
SE |
95% CI |
Connecticut |
347 |
49.1 |
4.1 |
(41.1 – 57.1) |
382 |
47.4 |
3.8 |
(40.0 – 54.8) |
Florida |
212 |
43.3 |
5.1 |
(33.3 – 53.3) |
236 |
40.6 |
4.8 |
(31.2 – 50.0) |
Georgia |
175 |
39.0 |
5.2 |
(28.8 – 49.2) |
177 |
42.0 |
5.4 |
(31.4 – 52.6) |
Hawaii |
162 |
46.2 |
6.2 |
(34.0 – 58.4) |
191 |
36.8 |
5.4 |
(26.2 – 47.4) |
Indiana |
206 |
45.3 |
6.6 |
(32.4 – 58.2) |
220 |
45.8 |
6.4 |
(33.3 – 58.3) |
Iowa |
181 |
51.0 |
5.4 |
(40.4 – 61.6) |
194 |
49.5 |
5.2 |
(39.3 – 59.7) |
Kansas |
589 |
55.3 |
2.7 |
(50.0 – 60.6) |
608 |
54.8 |
2.6 |
(49.7 – 59.9) |
Maine |
263 |
55.6 |
4.4 |
(47.0 – 64.2) |
274 |
54.4 |
4.4 |
(45.8 – 63.0) |
Massachusetts |
252 |
53.2 |
5.1 |
(43.2 – 63.2) |
278 |
47.6 |
4.7 |
(38.4 – 56.8) |
Michigan |
408 |
59.3 |
3.2 |
(53.0 – 65.6) |
439 |
55.3 |
3.2 |
(49.0 – 61.6) |
Minnesota |
604 |
43.9 |
2.6 |
(38.8 – 49.0) |
629 |
42.8 |
2.5 |
(37.9 – 47.7) |
Mississippi |
169 |
51.0 |
6.6 |
(38.1 – 63.9) |
174 |
48.9 |
6.9 |
(35.4 – 62.4) |
Missouri |
198 |
66.1 |
5.4 |
(55.5 – 76.7) |
206 |
65.7 |
5.3 |
(55.3 – 76.1) |
Montana |
142 |
59.6 |
6.8 |
(46.3 – 72.9) |
149 |
57.1 |
6.8 |
(43.8 – 70.4) |
Nebraska |
468 |
50.8 |
3.8 |
(43.4 – 58.2) |
500 |
47.4 |
3.9 |
(39.8 – 55.0) |
Nevada |
108 |
63.2 |
7.1 |
(49.3 – 77.1) |
114 |
65.0 |
6.8 |
(51.7 – 78.3) |
New Hampshire |
209 |
58.9 |
5.5 |
(48.1 – 69.7) |
215 |
55.6 |
5.6 |
(44.6 – 66.6) |
New Jersey |
418 |
34.7 |
3.9 |
(27.1 – 42.3) |
446 |
35.5 |
3.9 |
(27.9 – 43.1) |
New Mexico |
261 |
58.3 |
5.4 |
(47.7 – 68.9) |
277 |
61.9 |
4.8 |
(52.5 – 71.3) |
New York |
216 |
56.6 |
5.1 |
(46.6 – 66.6) |
239 |
55.6 |
4.9 |
(46.0 – 65.2) |
Ohio |
388 |
44.4 |
4.5 |
(35.6 – 53.2) |
426 |
41.2 |
4.0 |
(33.4 – 49.0) |
Oregon |
193 |
62.7 |
4.7 |
(53.5 – 71.9) |
217 |
57.9 |
4.7 |
(48.7 – 67.1) |
Pennsylvania |
206 |
43.4 |
5.9 |
(31.8 – 55.0) |
225 |
47.6 |
4.8 |
(38.2 – 57.0) |
Rhode Island |
203 |
55.9 |
6.1 |
(43.9 – 67.9) |
219 |
54.6 |
5.7 |
(43.4 – 65.8) |
Texas |
367 |
43.7 |
5.4 |
(33.1 – 54.3) |
421 |
41.6 |
4.8 |
(32.2 – 51.0) |
Utah |
371 |
48.2 |
3.4 |
(41.5 – 54.9) |
401 |
45.8 |
3.2 |
(39.5 – 52.1) |
Vermont |
249 |
49.8 |
4.2 |
(41.6 – 58.0) |
254 |
51.0 |
4.2 |
(42.8 – 59.2) |
Wisconsin |
282 |
60.1 |
4.5 |
(51.3 – 68.9) |
291 |
56.4 |
4.7 |
(47.2 – 65.6) |
Puerto Rico |
293 |
28.4 |
3.3 |
(21.9 – 34.9) |
328 |
31.3 |
3.2 |
(25.0 – 37.6) |
29 states / area |
8,140 |
49.3 |
1.3 |
(46.8 – 51.8) |
8,730 |
48.0 |
1.2 |
(45.6 – 50.4) |
Median |
|
51.0 |
|
|
|
48.9 |
|
|
Range |
|
28.4-66.1 |
|
|
|
31.3-65.7 |
|
|
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Landline and cell phone combined sample size excludes “DK/Refused”
§ Standard error
† Confidence interval